Tramadol Versus Celecoxib for Reducing Pain in Outpatient Hysteroscopy

• Register: ClinicalTrials.gov
• Last refreshed on: 19 February 2015
• Main ID: NCT02071303
• Date of registration: 23/02/2014
• Prospective Registration: Yes
• Primary sponsor: Cairo University
• Public title: Tramadol Versus Celecoxib for Reducing Pain in Outpatient Hysteroscopy
• Scientific title: Tramadol Versus Celecoxib for Reducing Pain Associated With Outpatient Hysteroscopy: A Randomized Double Blind Placebo-Controlled Trial
• Date of first enrolment: May 2014
• Target sample size: 210
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT02071303
• Study type: Interventional
• Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care
• Phase: Phase 2

Countries of recruitment

Egypt

Contacts

• Name: AbdelGany MA Hassan, MRCOG, MD
• Affiliation: Cairo University

Key inclusion & exclusion criteria

Inclusion Criteria:

- women referred to the outpatient hysteroscopy in Cairo university hospitals

- Consent to the procedure

Exclusion Criteria:

- Premenstrual patients

- Patients with missed periods

- Known cardiac disease

- Known gastritis or peptic ulcer

- Known allergy to Tramadol or Celecoxib



Age minimum: 18 Years
Age maximum: N/A
Gender: Female

Health Condition(s) or Problem(s) studied

Pain

Intervention(s)

Drug: Celecoxib

Drug: Tramadol

Drug: Placebo

Primary Outcome(s)

Pain perception during the procedure [Time Frame: 10 minutes after starting the procedure.]

Secondary Outcome(s)

Pain perception after the procedure [Time Frame: 30 minutes after the procedure.]

Secondary ID(s)

Gany-124

Source(s) of Monetary Support

Please refer to primary and secondary sponsors